The House on Sept. 30 passed a special appropriation of $ 15 mil. in a block grant to extend by six additional months a program to provide Burroughs Wellcome's Retrovir (zidovudine) to states for AIDS patients who cannot afford the drug ("The Pink Sheet" Sept. 19, "In Brief"). Under an unusual arrangement, $ 5 mil. of the funding is being provided through a one-time grant by Burroughs Wellcome. The Senate first passed the measure on Sept. 29.
You may also be interested in...
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Janssen presents highly encouraging interim results at ESMO from the CHRYSALIS study with a combination of amivantamab and lazertinib. Based on the data, the global Phase III MARIPOSA study, which will assess the combo versus blockbuster Tagrisso, will begin next month including in South Korea, home to lazertinib's originator.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.